M. Harsha

Acute Myocardial Infarction Following Intravenous Immunoglobulin Therapy in a Young Patient with Guillain–Barré Syndrome

Abstract Intravenous immunoglobulin (IVIG) is widely used for the treatment of autoimmune disorders such as Guillain–Barré syndrome (GBS) and is generally considered safe. However, rare but severe complications such as thromboembolic events, including myocardial infarction (MI),...